WHO ICTRP trial

REST: Randomised trial of an intervention targeting self-Efficacy to self-manage…

ACTRN12625000382471 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12625000382471
Public title REST: Randomised trial of an intervention targeting self-Efficacy to self-manage cancer-related fatigue in people with a primary brain Tumour
Scientific title REST: Randomised trial of an intervention targeting self-Efficacy to self-manage cancer-related fatigue in people with a primary brain Tumour
Primary sponsor University of Sydney
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Applicable
Countries Australia
Conditions Malignant Primary Brain Tumour;Cancer-related fatigue; Malignant Primary Brain Tumour Cancer-related fatigue;Cancer - Brain
Interventions An online intervention targeting self-efficacy to self-manage cancer-related fatigue (CRF). The online intervention consists of six sessions that will be completed across a 12 week period. Each session takes approximately 30 minutes to…
Registration date Apr 30, 2025
Target size 200
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations